The use of transvaginal ultrasound to aspirate bilateral hydrosalpinges prior to in vitro fertilization: a case report
- PMID: 1753167
- DOI: 10.1007/BF01130807
The use of transvaginal ultrasound to aspirate bilateral hydrosalpinges prior to in vitro fertilization: a case report
Abstract
Transvaginal ultrasound has recently been introduced diagnostically for follicular monitoring, early pregnancy localization (1), pelvic structure identification, early fetal development (2), detection of ovarian enlargement in postmenopausal women (3), and detection of endometrial carcinoma (4). Transvaginal ultrasound has had a major impact on patient monitoring and treatment for in vitro fertilization and embryo transfer (IVF/ET). Therapeutically transvaginal ultrasound has been introduced for oocyte retrieval and selective pregnancy reduction. The purpose of this paper is to present the therapeutic use of transvaginal ultrasound to aspirate large bilateral hydrosalpinges which complicated embryo transfer during an in vitro fertilization cycle.
Similar articles
-
Recurrence of hydrosalpinges after transvaginal aspiration of tubal fluid in an IVF cycle with development of a serometra.Hum Reprod. 1997 Apr;12(4):703-5. doi: 10.1093/humrep/12.4.703. Hum Reprod. 1997. PMID: 9159428
-
Ultrasound-guided aspiration of hydrosalpinges is associated with improved pregnancy and implantation rates after in-vitro fertilization cycles.Hum Reprod. 1998 Mar;13(3):736-9. doi: 10.1093/humrep/13.3.736. Hum Reprod. 1998. PMID: 9572444
-
A prospective clinical study of interventional ultrasound sclerotherapy on women with hydrosalpinx before in vitro fertilization and embryo transfer.Fertil Steril. 2010 Dec;94(7):2854-6. doi: 10.1016/j.fertnstert.2010.06.065. Epub 2010 Aug 1. Fertil Steril. 2010. PMID: 20674895 Clinical Trial.
-
The management of hydrosalpinges before in-vitro fertilization and embryo transfer.Curr Opin Obstet Gynecol. 1998 Jun;10(3):233-8. doi: 10.1097/00001703-199806000-00010. Curr Opin Obstet Gynecol. 1998. PMID: 9619347 Review.
-
How to treat hydrosalpinges: IVF as the treatment of choice.Reprod Biomed Online. 2002;4 Suppl 3:37-9. doi: 10.1016/s1472-6483(12)60114-x. Reprod Biomed Online. 2002. PMID: 12470563 Review.
Cited by
-
The presence of hydrosalpinx may not adversely affect the implantation and pregnancy rates in in vitro fertilization treatment.J Assist Reprod Genet. 1997 Oct;14(9):508-12. doi: 10.1023/a:1021123309392. J Assist Reprod Genet. 1997. PMID: 9401868 Free PMC article.
-
An increased number of replaced embryos counteracts the adverse effect of hydrosalpinges on IVF/ET outcome.J Assist Reprod Genet. 1998 Jan;15(1):22-6. doi: 10.1023/a:1022522204277. J Assist Reprod Genet. 1998. PMID: 9493062 Free PMC article.
-
The effect of hydrosalpinges on IVF-ET outcome.J Assist Reprod Genet. 1999 Aug;16(7):350-4. doi: 10.1023/a:1020585728549. J Assist Reprod Genet. 1999. PMID: 10459516 Free PMC article. Clinical Trial.
-
Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD002125. doi: 10.1002/14651858.CD002125.pub3. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2020 Oct 22;10:CD002125. doi: 10.1002/14651858.CD002125.pub4. PMID: 20091531 Free PMC article. Updated.